Authors/Disclosures
|
Gudarz Davar, MD
(Allergan, Inc.)
|
No disclosure on file |
|
Sandra R. Richman, MD
|
No disclosure on file |
|
Fariha Khalid, MD
(Brigham And Women's Hospital)
|
No disclosure on file |
|
|
No disclosure on file |
|
Gabrielle Glick
(Biogen Idec)
|
No disclosure on file |
|
Meena Subramanyam, PhD
|
No disclosure on file |
|
Xiao Hu, PhD
(Biogen Idec)
|
No disclosure on file |
|
|
No disclosure on file |
|
Shifang Liu
|
No disclosure on file |
|
Ying Zhu
|
No disclosure on file |
|
Michael A. Panzara, MD, MPH
|
Dr. Panzara has received personal compensation for serving as an employee of Neurvati Neurosciences. Dr. Panzara has received personal compensation for serving as an employee of GRIN Therapeutics. Dr. Panzara has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Wave Life Sciences. Dr. Panzara has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Athira Pharma. Dr. Panzara has stock in GRIN Therapeutics. Dr. Panzara has stock in Cadenza Bio. Dr. Panzara has stock in Athira Pharma. Dr. Panzara has stock in Wave Life Sciences. Dr. Panzara has stock in Sanofi. |